AML, acute myeloblastic leukemia; ALL, acute lymphoblastic leukemia; MDS, myelodysplastic syndrome; MM, multiple myeloma; NHL, non-Hodgkin lymphoma; HL, Hodgkin lymphoma; CMPD, chronic myeloproliferative disease; PNH, paroxysmal nocturnal hemoglobinuria; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; GVHD, graft-versus-host disease; TRM, transplant-related mortality; OS, overall survival; G-CSF, granulocyte colony-stimulating factor. This evidence concerns the gene CSF3 and non-Hodgkin lymphoma.